Jobs
Benefits & Perks
•Healthcare
•401(k)
•Equity
•Parental Leave
•Learning Budget
•Gym
•Healthcare
•401k
•Equity
•Parental Leave
•Learning
•Gym
Required Skills
Go-to-market strategy
Sales force design
Field structure design
Customer insights
Cross-functional collaboration
Decision-making
Communication
About This Role
As the Director of Nephrology Commercial Model Design, you will lead the lead the development of the US go-to-market model for a late-stage pipeline therapeutic for several rare Nephrology conditions. You will be responsible for determining the optimal go-to-market model, including field resources and structure, patient support model, multi-channel strategy, etc. In addition to broad model design, this role will also focus on developing the site-of-care strategy, especially with regard to infusion sites.
You will report directly to the US Nephrology Franchise Head and be a core member of the US Launch Operating Team. This role offers you an exceptional opportunity to impact a therapeutic area with significant unmet needs while working alongside a dedicated cross-functional team.
What You’ll Do
-
Define and evolve the U.S. go-to-market model in collaboration with US and global brand strategy leads
-
Partner with Insights & Analytics to drive market research required to inform the go-to-market model, including customer segmentation and targeting
-
Engage with key customers and KOLs to understand potential future challenges and bottlenecks to the use of our nephrology portfolio
-
Design the optimal field structure to support the launch of nephrology assets, collaborating with Business Intelligence & Operations to drive size and footprint recommendations
-
Partner with Patient Services to determine the optimal patient support model for future nephrology patients
-
Create and execute a comprehensive plan for building out the various elements of the go-to-market plan in the run-up to and during launch, and closely interacting with other functions to manage interdependencies
-
Contribute to the development of the annual brand plan with the US brand lead, and ensuring alignment with the Global team
-
Frequently interact with Sales, Marketing, Training, Advocacy, Public Affairs, Patient Services, Market Research/Decision Support, Market Access & Reimbursement, Legal, Compliance and Regulatory within the US Launch Operating Team, as well as the Global Launch Team
Who You Are
You thrive in complex environments, bringing innovative solutions to the table. You possess excellent communication skills, enabling effective collaboration across teams and with external partners. Your commitment to putting patients first and your respect for science drive your decision-making and initiatives.
Required Skills
-
Bachelor's degree required; MBA or other advanced degree preferred
-
10+ years of pharmaceutical or biotech commercial experience or equivalent consulting experience
-
US pharmaceutical launch experience (as it relates to designing go-to-market models) strongly preferred
-
Proven track record in using customer and marketplace insights to develop initiatives that meet both customer and company needs
-
Expertise in sales force/field design, especially within an account selling model
-
Experience working in a cross-functional, matrixed environment
-
Ability to make astute decisions and adapt with agility as new information emerges
-
Self-starter capable of delivering results in a fast-paced and challenging environment
-
Effective communication skills, including with customers
Preferred Skills
-
Buy & bill experience
-
Experience in Nephrology, Transplant, or Rare Disease
Job Level: Management
Additional Information:
The base compensation range for this role is: $199,000.00-$274,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Tax Director, Corporate Tax Planning and M&A
OpenAI · San Francisco

Associate Director - HR, Global L&D - Learning Design Innovation
Eli Lilly · US: USA Remote

Finance Cost and Inventory Director
GlobalFoundries · 2 Locations

Director, Enterprise Compliance Corrections
Centene · Remote-MO

Associate Director
Cushman & Wakefield · CW Site - AUS - Perth - L14, 225 St Georges Terrace
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago